Detalhe da pesquisa
1.
Early assessment of the pharmacokinetic and pharmacodynamic effects following acetylsalicylic acid loading: toward a definition for acute therapeutic response.
J Thromb Thrombolysis
; 57(1): 21-28, 2024 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-38066385
2.
Utility of VerifyNow to assess the immediate pharmacodynamic response of chewed and swallowed aspirin: comparison with aggregometry.
Platelets
; 35(1): 2298352, 2024 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-38166614
3.
Prognostic impact of hypercoagulability and impaired fibrinolysis in acute myocardial infarction.
Eur Heart J
; 44(19): 1718-1728, 2023 05 14.
Artigo
Inglês
| MEDLINE | ID: mdl-36857519
4.
Deficiency of MMP1a (Matrix Metalloprotease 1a) Collagenase Suppresses Development of Atherosclerosis in Mice: Translational Implications for Human Coronary Artery Disease.
Arterioscler Thromb Vasc Biol
; 41(5): e265-e279, 2021 05 05.
Artigo
Inglês
| MEDLINE | ID: mdl-33761760
5.
Metformin use in patients hospitalized with COVID-19: lower inflammation, oxidative stress, and thrombotic risk markers and better clinical outcomes.
J Thromb Thrombolysis
; 53(2): 363-371, 2022 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-35041121
6.
Serial assessment of thrombogenicity and hemodynamics in patients with type II diabetes in a clinical research unit: Evidence for circadian variations in clot formation.
J Thromb Thrombolysis
; 54(3): 393-400, 2022 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-36074227
7.
The role of viscoelastic testing in assessing peri-interventional platelet function and coagulation.
Platelets
; 33(4): 520-530, 2022 May 19.
Artigo
Inglês
| MEDLINE | ID: mdl-34369848
8.
PAR1 (Protease-Activated Receptor 1) Pepducin Therapy Targeting Myocardial Necrosis in Coronary Artery Disease and Acute Coronary Syndrome Patients Undergoing Cardiac Catheterization: A Randomized, Placebo-Controlled, Phase 2 Study.
Arterioscler Thromb Vasc Biol
; 40(12): 2990-3003, 2020 12.
Artigo
Inglês
| MEDLINE | ID: mdl-33028101
9.
Defining platelet response to acetylsalicylic acid: the relation between inhibition of serum thromboxane B2 and agonist-induced platelet aggregation.
J Thromb Thrombolysis
; 51(2): 260-264, 2021 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-33170486
10.
Clinical validation of AggreGuide A-100 ADP, a novel assay for assessing the antiplatelet effect of oral P2Y12 antagonists.
J Thromb Thrombolysis
; 52(1): 272-280, 2021 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-34143384
11.
Detailed thrombogenicity phenotyping and 1 year outcomes in patients undergoing WATCHMAN implantation: (TARGET-WATCHMAN) a case-control study.
J Thromb Thrombolysis
; 50(3): 484-498, 2020 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-32601850
12.
Noncanonical Matrix Metalloprotease 1-Protease-Activated Receptor 1 Signaling Drives Progression of Atherosclerosis.
Arterioscler Thromb Vasc Biol
; 38(6): 1368-1380, 2018 06.
Artigo
Inglês
| MEDLINE | ID: mdl-29622563
13.
"Blueprinting" thrombogenicity and antithrombotic drug response at the bedside in patients presenting emergently with symptoms of acute stroke.
J Thromb Thrombolysis
; 47(2): 192-199, 2019 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-30673942
14.
Thromboembolism after WATCHMANTM in a clopidogrel non-responder: A case for concern?
Catheter Cardiovasc Interv
; 92(1): 200-202, 2018 07.
Artigo
Inglês
| MEDLINE | ID: mdl-29130638
15.
Thromboxane inhibition during concurrent therapy with low-dose aspirin and over-the-counter naproxen sodium.
J Thromb Thrombolysis
; 45(1): 18-26, 2018 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-29198079
16.
Evaluation of potential antiplatelet effects of CSL112 (Apolipoprotein A-I [Human]) in patients with atherosclerosis: results from a phase 2a study.
J Thromb Thrombolysis
; 45(4): 469-476, 2018 May.
Artigo
Inglês
| MEDLINE | ID: mdl-29582212
17.
Implantable Cardioverter-Defibrillators for Primary Prevention in Patients With Ischemic or Nonischemic Cardiomyopathy: A Systematic Review and Meta-analysis.
Ann Intern Med
; 167(2): 103-111, 2017 Jul 18.
Artigo
Inglês
| MEDLINE | ID: mdl-28632280
18.
Cell-Penetrating Pepducin Therapy Targeting PAR1 in Subjects With Coronary Artery Disease.
Arterioscler Thromb Vasc Biol
; 36(1): 189-97, 2016 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-26681756
19.
Central aortic pulse pressure, thrombogenicity and cardiovascular risk.
J Thromb Thrombolysis
; 44(2): 223-233, 2017 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-28695310
20.
Determination of non-Vitamin K oral anticoagulant (NOAC) effects using a new-generation thrombelastography TEG 6s system.
J Thromb Thrombolysis
; 43(4): 437-445, 2017 May.
Artigo
Inglês
| MEDLINE | ID: mdl-28247290